ADA and hyperuricemia: In conclusion, the results indicated that CCE exhibits a significant anti-hyperuricemia effect, and the mechanism of action is associated with its anti-inflammatory activity by reversing the elevation of renal inflammatory cytokines, restoring the disordered metabolic pathways, and inhibiting the expression of ADA, PNP, and JUN mRNA in renal tissues.